欢迎来到 CSNpharm! 产品仅用于科研!
首页 400-920-2911

CCR

CCR

货号 产品名 CAS号 信息
CSN12197 Vicriviroc Maleate 599179-03-0 Vicriviroc maleate is a CCR5 antagonist with IC50 of 0.91 nM in clinical development for the treatment of HIV-1.
CSN18397 Vercirnon 698394-73-9 Vercirnon is a highly potent antagonist of CCR9, which has been implicated in the aetiology of inflammatory bowel diseases such as Crohn's disease.
CSN16904 TAK-220 333994-00-6 TAK-220 is an orally bioavailable small-molecule CCR5 antagonist.
CSN22613 SB297006 58816-69-6 SB297006 is a selective antagonist of CCR3 with IC50 of 39 nM.
CSN18192 RS-102895 300815-41-2 RS102895 is a potent and specific CCR2 antagonist with binding IC50 of 360 nM, no significant inhibition on CCR1 (IC50 > 17 μM).
CSN13797 RS-102895 HCl 1173022-16-6 RS102895 hydrochloride is a potent and specific CCR2 antagonist with binding IC50 of 360 nM, no significant inhibition on CCR1 (IC50 > 17 μM).
CSN12845 RS-504393 300816-15-3 RS 504393 is a selective CCR2 chemokine receptor antagonist (IC50 values are 98 nM and > 100 μM for inhibition of human recombinant CCR2b and CCR1 receptors respectively).
CSN17712 PF-4136309   1341224-83-6 PF-4136309 is a potent, Selective, and orally bioavailable CCR2 antagonist.
CSN17807 NSC 5844 140926-75-6 NSC 5844 is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.
CSN18995 MK-0812 Succinate 851916-42-2 MK-0812 succinate is a potent and selective CCR2 antagonist with low nM affinity for CCR2 on human monocytes.
CSN13664 MK-0812 624733-88-6 MK-0812 is a potent and selective CCR2 antagonist with low nM affinity for CCR2 on human monocytes.
CSN11361 Maraviroc 376348-65-1 Maraviroc is a selective CCR5 antagonist (IC50= 6.4 nM) and displays potent anti-HIV-1 activity.
CSN17640 INCB3344 1262238-11-8 INCB3344 is a potent and selective small molecule antagonist of the mouse CCR2 receptor and inhibits the binding of CCL2 to mouse monocytes with nanomolar potency (IC50 = 10 nM).
CSN13799 INCB 3284 Dimesylate 887401-93-6 INCB 3284 is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM.
CSN18528 INCB 3284 887401-92-5 INCB 3284 is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM (inhibition of monocyte chemoattractant protein-1 binding to hCCR2).
CSN22186 GW 766994 408303-43-5 GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist, which has entered clinical trial for asthma and eosinophilic bronchitis.
CSN22234 GSK2239633A 1240516-71-5 GSK2239633A is a CC-chemokine receptor 4 (CCR4) antagonist, which inhibits the binding of [125I]-TARC to human CCR4 with a pIC50 of 7.96 ± 0.11.
CSN23233 DAPTA 106362-34-9 DAPTA is a potent and selective CCR5 antagonist.
CSN15987 Cenicriviroc 497223-25-3 Cenicriviroc is an oral, dual CCR2/CCR5 antagonist, and displays potent anti-inflammatory and aninfective activity.
CSN22175 CCR5 Antagonist 1 716354-86-8 CCR5 antagonist 1 is a CCR5 antagonist which can inhibit HIV replication extracted from WO 2004054974 A2.
CSN18114 BX471 217645-70-0 BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
CSN18182 BX471 HCl 288262-96-4 BX471 hydrochloride is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.
CSN20665 AZD-2098 566203-88-1 AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor, used for asthma research.
CSN20666 AZD-1678 942137-41-9 AZD1678 is a potent CC-chemokine receptor 4 (CCR4) inhibitor, used for asthma research.
CSN22732 C 021 2HCl 864289-85-0
CSN22729 BX 513 HCl 1216540-18-9
CSN22720 BMS CCR2 22 445479-97-0
CSN23102 SB 328437 247580-43-4
CSN23164 Teijin Compound 1 1313730-14-1
<< PREV 1 NEXT >>